Sang-Yun Lee
MD, PhD, Prof
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Background Hemodynamically significant patent ductus arteriosus (hsPDA) leads to left‐sided chamber dilatation and mitral valve (MV) annular stretching, potentially resulting in mitral regurgitation (MR). While transcatheter PDA closure often improves MR, persistent MR may be associated with adverse outcomes. This study aimed to identify echocardiographic predictors of persistent MR following transcatheter PDA closure in pediatric patients. Methods We conducted a retrospective study of 183 pediatric patients (aged 1–18 years) who underwent transcatheter PDA closure at Seoul National University Hospital between 2004 and 2021. Echocardiographic parameters, including left ventricular internal diameter in diastole (LVIDd), MV annulus diameter, and MR severity were analyzed before and after the procedure. Cardiac catheterization data were also reviewed. Results The mean age at the time of the procedure was 1.92 years, and the average pulmonic end diameter of PDA was 2.91 mm. After transcatheter PDA closure, LVIDd (Z‐score), LVIDd/BSA, and MV annulus (Z‐score) significantly decreased. The prevalence of MR decreased from 22.4% (preclosure) to 8.2% (postclosure). Multivariate analysis identified preclosure LVIDd (Z‐score), postclosure MV annulus diameter (mm), MV annulus (Z‐score), and the presence of MV prolapse as independent predictors of persistent MR. ROC analysis demonstrated that a preclosure LVIDd (Z‐score) ≥ 2.95 predicted persistent MR with a sensitivity of 66.7% and a specificity of 83.9%. Conclusions Persistent MR after transcatheter PDA closure is predicted by preclosure LVIDd (Z‐score), postclosure MV annulus diameter, and the presence of MV prolapse. Recognizing these factors may help guide clinical management and improve outcomes for patients at the risk of persistent MR.
Year:
2026
Kawasaki disease (KD) is an acute vasculitis that primarily affects children and can lead to severe coronary artery complications, including total occlusion. This study evaluates the long-term outcomes of conservative management in patients with right coronary artery (RCA) total occlusion following KD. A retrospective review of 78 patients who underwent cardiac computed tomography (CT) between 2000 and 2022 identified seven cases of RCA total occlusion. The median duration from KD diagnosis to RCA occlusion was 2.3 years (range: 0.5–5.7 years). Among seven patients, four patients remained asymptomatic and three experienced mild chest pain. Follow-up assessments, including electrocardiogram, echocardiography, treadmill tests, and myocardial perfusion single-proton emission computed tomography (SPECT), revealed no significant ischemic findings. All patients maintained functional status within New York Heart Association class I over a median follow-up of 7.2 years (range: 1.0–13.5 years). Treatment primarily consisted of triple antithrombotic therapy, including aspirin, clopidogrel, and warfarin, with transient use of low-molecular-weight heparin in select cases. Our findings suggest that conservative management with medical therapy and regular follow-up may be a viable approach for patients with RCA occlusion who exhibit no ischemic symptoms. The development of collateral circulation may play a critical role in preventing myocardial ischemia. However, further studies with larger cohorts and advanced imaging techniques are needed to refine management strategies and assess long-term outcomes.
Year:
2025
After an arterial switch operation for complete transposition of the great arteries, neo-aortic root dilatation occurs, with unclear hemodynamic effects. This study analyzes three groups (severe dilation, mild dilation, and normal) using computational fluid dynamics (CFD) on cardiac CT scans. Aortic arch angles in severe (median 72.3, range: 68.5–77.2) and mild dilation (76.6, 71.1–85.2) groups are significantly smaller than the normal group (97.3, 87.4–99.0). In the normal and mild dilatation groups, Wall Shear Stress (WSS) exhibits a consistent pattern: it is lowest at the aortic root, gradually increases until just before the bend in the aortic arch, peaks, and then subsequently decreases. However, severe dilation shows disrupted WSS patterns, notably lower in the distal ascending aorta, attributed to local recirculation. This unique WSS pattern observed in severely dilated patients, especially in the transverse aorta. CFD plays an essential role in comprehensively studying the pathophysiology underlying aortic dilation in this population. Graphical Abstract
Year:
2024
Background Heart transplantation is often limited by the availability of transplantable donor heart and understanding of donor aspects that would influence transplant outcomes becomes important. In this study, donor characteristics and their impact on the outcomes of pediatric heart transplantations performed in South Korea were investigated. Methods We reviewed the medical records of patients less than 18 years old who received heart transplantation between 2002 and 2022 in three tertiary hospitals located in South Korea. Results A total of 139 cases were enrolled. One‐year mortality was 10.4% and total mortality was 33.8%. Forty‐nine recipients (35.3%) showed biopsy‐proven rejections and 20 (14.4%) showed cardiac allograft vasculopathy during mean follow‐up of 6.4 ± 4.9 years. Six recipients (4.5%) showed left ventricle ejection fraction of less than 55% post‐transplantation. The mean age of the donors was 23.0 ± 15.4 years. The most common cause of death of the donors was unspecified illness (46.4%). Donors with a history of diabetes, hypertension, smoking, and alcohol consumption were 0%, 3.1%, 32.1%, and 34.4%, respectively. Mean total ischemic time was 191.6 ± 72.7 min, while total ischemic time was over 4 h in 37 patients (26.6%). There were no significant relationship between donor factors and survival. However, donor's history of drinking or cardiopulmonary resuscitation was significantly associated with acute rejection and donor's age with cardiac allograft vasculopathy. Conclusion Donor factors did not show significant impact on post‐transplant survival but some factors were predictive of post‐transplant rejection and cardiac allograft vasculopathy.
Year:
2024
Background Pulsta valve is increasingly used for percutaneous pulmonary valve implantation (PPVI) in patients with a large native right ventricular outflow tract (RVOT). This study aims to elucidate the outcomes of Pulsta valve implantation within the native RVOT and assess its adaptability to various native main pulmonary artery (PA) anatomies. Methods A multicenter retrospective study included 182 patients with moderate to severe pulmonary regurgitation in the native RVOT who underwent PPVI with Pulsta valves® between February 2016 and August 2023 at five Korean and Taiwanese tertiary referral centers. Results Pulsta valve implantation was successful in 179 out of 182 patients (98.4%) with an average age of 26.7 ± 11.0 years. The median follow‐up duration was 29 months. Baseline assessments revealed enlarged right ventricle (RV) volume (mean indexed RV end‐diastolic volume: 163.1 (interquartile range, IQR: 152.0–180.3 mL/m²), which significantly decreased to 123.6(IQR: 106.6–137.5 mL/m 2 after 1 year. The main PA types were classified as pyramidal (3.8%), straight (38.5%), reverse pyramidal (13.2%), convex (26.4%), and concave (18.1%) shapes. Pulsta valve placement was adapted, with distal main PA for pyramidal shapes and proximal or mid‐PA for reverse pyramidal shapes. Two patients experienced Pulsta valve embolization to RV, requiring surgical removal, and one patient encountered valve migration to the distal main PA, necessitating surgical fixation. Conclusions Customized valve insertion sites are pivotal in self‐expandable PPVI considering diverse native RVOT shape. The rather soft and compact structure of the Pulsta valve has characteristics to are adaptable to diverse native RVOT geometries.
Year:
2024
Collaborators (4)
Jinyoung Song
professor
Samsung Medical Center
Ah Young Kim
-
Jae Young Choi
Yonsei University College of Medicine
Eun Jung Bae
-
Make your next move.
Prepare your application
Review drafts before you send them.